4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001209191-18-039558
Options or other derivatives
- Chief Operating Officer acquired 300,000 shares (grant or award)
From the SEC's structured data for this filing
Eloxx Pharmaceuticals, Inc. Filed Acc 0001209191-18-039558
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…